Kazuto Nishio

41PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 07, 2026
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.

|Mar 11, 2026
Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi

|Feb 02, 2026
Clonal Complexity Defines Distinct Tumor-Intrinsic Biology and Prognosis in Diffuse Large B-Cell Lymphoma.

Takahiro Haeno, Kazuko Sakai, Shuji Minamoto

|Nov 13, 2025
Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-Overexpression.

Takashi Kurosaki, Shinichiro Suzuki, Kimio Yonesaka

|Nov 10, 2025
Ovarian Epithelioid Tumor With FUS::CREM Fusion in a 63-Year-Old Woman: A Case Report of an Emerging Entity Associated With Systemic Inflammation.

Hiroshi Kajiyama, Yoko Kashima, Tomoyuki Otani

|Sep 27, 2025
Cure of Recurrent Ovarian Cancer: A Multicenter Retrospective Study.

Masahiro Sumitomo, Yasushi Kotani, Kosuke Murakami

Pageof 7